Status:
COMPLETED
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
Lead Sponsor:
Galderma R&D
Conditions:
Skin Irritation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin
Eligibility Criteria
Inclusion
- Age 18-65 years
- Good health
- willingness to cooperate and participate
- willingness to avoid topical products at test sites
- willingness to avoid direct sun exposure to test sites
Exclusion
- Individuals with active psoriasis or eczema
- individuals with sunburn, acne, abrasions, scar tissue, or tattoos on test sites, or disease of skin that might interfere
- individuals who have had a mastectomy with axillary nodes were removed
- individuals receiving anticancer, immunosuppressive treatments or medications, or radiation
- pregnant, nursing, or planned to become pregnant
- use of topical steroids or drugs at test sites
- active or untreated skin cancer
- active hepatitis
- current routine or frequent use of high doses of anti-inflammatory drugs
- individuals who have had les than two week rest period since completion of previous patch testing on upper back or upper arms
- individuals with uncontrolled metabolic diseases
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT01892423
Start Date
August 1 2006
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas J Stephens and Associates Inc
Carrollton, Texas, United States, 75006